Healthcare remains a top priority for antitrust enforcement, with regulators closely examining evolving industry dynamics. Companies in this sector must stay alert to shifting risks and enforcement focus areas.
In this video, DC partner Chris Gordon highlights three key antitrust risk areas for healthcare companies in 2026 and explains how changing enforcement priorities are shaping scrutiny across the industry.
